Atlas Trials

Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate

Clinical trial NCT02532842 · COMPLETED

Trial details

NCT number
NCT02532842
Sponsor
Janssen Pharmaceutica N.V., Belgium
Status
COMPLETED
Study type
OBSERVATIONAL
Schizophrenia
Start date
2015-07-01
Primary completion
2015-09-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.